# Nextdoor Holdings, Inc.: financial statements, quarterly

NXDR · Nasdaq · CIK 1846069 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/nxdr.md) · [Financials](/companies/nxdr/financials.md) · [Filings](/companies/nxdr/filings.md) · [Insiders](/companies/nxdr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/nxdr/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [56.1](/filings/0001846069-24-000226.md) | [55.6 d](/filings/0001846069-26-000023.md) | [53.1](/filings/0001846069-25-000061.md) | [63.3](/filings/0001846069-25-000103.md) | [65.6](/filings/0001846069-25-000136.md) | [65.2 d](/filings/0001846069-26-000023.md) | [54.2](/filings/0001846069-26-000098.md) | [65.1](/filings/0001846069-26-000155.md) | [68.9](/filings/0001846069-25-000136.md) | [69.5 d](/filings/0001846069-26-000023.md) | [61.7](/filings/0001846069-26-000098.md) | [74.6](/filings/0001846069-26-000155.md) |
| Cost of revenue | $m | [10.7](/filings/0001846069-24-000226.md) | [10.5 d](/filings/0001846069-26-000023.md) | [10.0](/filings/0001846069-25-000061.md) | [10.3](/filings/0001846069-25-000103.md) | [11.1](/filings/0001846069-25-000136.md) | [10.5 d](/filings/0001846069-26-000023.md) | [9.4](/filings/0001846069-26-000098.md) | [10.6](/filings/0001846069-26-000155.md) | [10.4](/filings/0001846069-25-000136.md) | [10.5 d](/filings/0001846069-26-000023.md) | [11.0](/filings/0001846069-26-000098.md) | [11.5](/filings/0001846069-26-000155.md) |
| Research and development | $m | [39.6](/filings/0001846069-24-000226.md) | [40.3 d](/filings/0001846069-26-000023.md) | [31.3](/filings/0001846069-25-000061.md) | [31.1](/filings/0001846069-25-000103.md) | [31.9](/filings/0001846069-25-000136.md) | [33.6 d](/filings/0001846069-26-000023.md) | [33.5](/filings/0001846069-26-000098.md) | [34.6](/filings/0001846069-26-000155.md) | [35.7](/filings/0001846069-25-000136.md) | [31.4 d](/filings/0001846069-26-000023.md) | [32.0](/filings/0001846069-26-000098.md) | [33.0](/filings/0001846069-26-000155.md) |
| Operating income | $m | [(44.4)](/filings/0001846069-24-000226.md) | [(47.7) d](/filings/0001846069-26-000023.md) | [(34.7)](/filings/0001846069-25-000061.md) | [(49.0)](/filings/0001846069-25-000103.md) | [(20.8)](/filings/0001846069-25-000136.md) | [(17.1) d](/filings/0001846069-26-000023.md) | [(27.0)](/filings/0001846069-26-000098.md) | [(20.3)](/filings/0001846069-26-000155.md) | [(17.2)](/filings/0001846069-25-000136.md) | [(7.4) d](/filings/0001846069-26-000023.md) | [(15.3)](/filings/0001846069-26-000098.md) | [(5.7)](/filings/0001846069-26-000155.md) |
| Income tax | $m | [0.3](/filings/0001846069-24-000226.md) | [0.0 d](/filings/0001846069-26-000023.md) | [0.2](/filings/0001846069-25-000061.md) | [0.3](/filings/0001846069-25-000103.md) | [0.2](/filings/0001846069-25-000136.md) | [0.0 d](/filings/0001846069-26-000023.md) | [0.1](/filings/0001846069-26-000098.md) | [0.3](/filings/0001846069-26-000155.md) | [0.1](/filings/0001846069-25-000136.md) | [1.1 d](/filings/0001846069-26-000023.md) | [0.1](/filings/0001846069-26-000098.md) | [0.3](/filings/0001846069-26-000155.md) |
| Net income | $m | [(38.1)](/filings/0001846069-24-000226.md) | [(40.5) d](/filings/0001846069-26-000023.md) | [(28.3)](/filings/0001846069-25-000061.md) | [(42.8)](/filings/0001846069-25-000103.md) | [(14.9)](/filings/0001846069-25-000136.md) | [(12.1) d](/filings/0001846069-26-000023.md) | [(22.0)](/filings/0001846069-26-000098.md) | [(15.4)](/filings/0001846069-26-000155.md) | [(12.9)](/filings/0001846069-25-000136.md) | [(4.0) d](/filings/0001846069-26-000023.md) | [(11.4)](/filings/0001846069-26-000098.md) | [(2.1)](/filings/0001846069-26-000155.md) |
| Diluted EPS | $ per share | [(0.10)](/filings/0001846069-24-000226.md) | not reported | [(0.07)](/filings/0001846069-25-000061.md) | [(0.11)](/filings/0001846069-25-000103.md) | [(0.04)](/filings/0001846069-25-000136.md) | not reported | [(0.06)](/filings/0001846069-26-000098.md) | [(0.04)](/filings/0001846069-26-000155.md) | [(0.03)](/filings/0001846069-25-000136.md) | not reported | [(0.03)](/filings/0001846069-26-000098.md) | [(0.01)](/filings/0001846069-26-000155.md) |
| Basic EPS | $ per share | [(0.10)](/filings/0001846069-24-000226.md) | not reported | [(0.07)](/filings/0001846069-25-000061.md) | [(0.11)](/filings/0001846069-25-000103.md) | [(0.04)](/filings/0001846069-25-000136.md) | not reported | [(0.06)](/filings/0001846069-26-000098.md) | [(0.04)](/filings/0001846069-26-000155.md) | [(0.03)](/filings/0001846069-25-000136.md) | not reported | [(0.03)](/filings/0001846069-26-000098.md) | [(0.01)](/filings/0001846069-26-000155.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [48.4](/filings/0001846069-24-000226.md) | [60.2](/filings/0001846069-26-000023.md) | [69.7](/filings/0001846069-25-000061.md) | [53.0](/filings/0001846069-25-000103.md) | [49.7](/filings/0001846069-25-000136.md) | [45.6](/filings/0001846069-26-000023.md) | [57.3](/filings/0001846069-26-000098.md) | [62.1](/filings/0001846069-26-000155.md) | [56.1](/filings/0001846069-25-000136.md) | [63.3](/filings/0001846069-26-000155.md) | [56.1](/filings/0001846069-26-000098.md) | [63.6](/filings/0001846069-26-000155.md) |
| Current assets | $m | [581](/filings/0001846069-23-000122.md) | [567](/filings/0001846069-25-000017.md) | [540](/filings/0001846069-24-000127.md) | [493](/filings/0001846069-24-000201.md) | [469](/filings/0001846069-24-000226.md) | [467](/filings/0001846069-26-000023.md) | [452](/filings/0001846069-25-000061.md) | [448](/filings/0001846069-25-000103.md) | [448](/filings/0001846069-25-000136.md) | [448](/filings/0001846069-26-000155.md) | [416](/filings/0001846069-26-000098.md) | [426](/filings/0001846069-26-000155.md) |
| Total assets | $m | [670](/filings/0001846069-23-000122.md) | [655](/filings/0001846069-25-000017.md) | [633](/filings/0001846069-24-000127.md) | [542](/filings/0001846069-24-000201.md) | [518](/filings/0001846069-24-000226.md) | [514](/filings/0001846069-26-000023.md) | [495](/filings/0001846069-25-000061.md) | [490](/filings/0001846069-25-000103.md) | [489](/filings/0001846069-25-000136.md) | [487](/filings/0001846069-26-000155.md) | [453](/filings/0001846069-26-000098.md) | [462](/filings/0001846069-26-000155.md) |
| Current liabilities | $m | [34.6](/filings/0001846069-23-000122.md) | [35.4](/filings/0001846069-25-000017.md) | [32.7](/filings/0001846069-24-000127.md) | [32.7](/filings/0001846069-24-000201.md) | [26.8](/filings/0001846069-24-000226.md) | [27.9](/filings/0001846069-26-000023.md) | [28.6](/filings/0001846069-25-000061.md) | [32.8](/filings/0001846069-25-000103.md) | [33.4](/filings/0001846069-25-000136.md) | [31.9](/filings/0001846069-26-000155.md) | [29.7](/filings/0001846069-26-000098.md) | [32.1](/filings/0001846069-26-000155.md) |
| Total liabilities | $m | [96.9](/filings/0001846069-23-000122.md) | [96.0](/filings/0001846069-25-000017.md) | [91.6](/filings/0001846069-24-000127.md) | [69.8](/filings/0001846069-24-000201.md) | [61.6](/filings/0001846069-24-000226.md) | [60.5](/filings/0001846069-26-000023.md) | [58.9](/filings/0001846069-25-000061.md) | [60.8](/filings/0001846069-25-000103.md) | [59.3](/filings/0001846069-25-000136.md) | [55.5](/filings/0001846069-26-000155.md) | [51.0](/filings/0001846069-26-000098.md) | [51.2](/filings/0001846069-26-000155.md) |
| Shareholders' equity | $m | [573](/filings/0001846069-24-000226.md) | [559](/filings/0001846069-26-000023.md) | [541](/filings/0001846069-25-000103.md) | [472](/filings/0001846069-25-000136.md) | [456](/filings/0001846069-25-000136.md) | [453](/filings/0001846069-26-000155.md) | [436](/filings/0001846069-26-000155.md) | [430](/filings/0001846069-26-000155.md) | [430](/filings/0001846069-25-000136.md) | [431](/filings/0001846069-26-000155.md) | [401](/filings/0001846069-26-000155.md) | [411](/filings/0001846069-26-000155.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(18.3) d](/filings/0001846069-24-000226.md) | [(14.9) d](/filings/0001846069-26-000023.md) | [(13.6)](/filings/0001846069-25-000061.md) | [(5.4) d](/filings/0001846069-25-000103.md) | [(13.0) d](/filings/0001846069-25-000136.md) | [11.8 d](/filings/0001846069-26-000023.md) | [0.4](/filings/0001846069-26-000098.md) | [2.9 d](/filings/0001846069-26-000155.md) | [(6.3) d](/filings/0001846069-25-000136.md) | [9.5 d](/filings/0001846069-26-000023.md) | [1.2](/filings/0001846069-26-000098.md) | [8.4 d](/filings/0001846069-26-000155.md) |
| Capital expenditure | $m | [0.1 d](/filings/0001846069-24-000226.md) | [(0.0) d](/filings/0001846069-26-000023.md) | [0.0](/filings/0001846069-25-000061.md) | [0.1 d](/filings/0001846069-25-000103.md) | [0.2 d](/filings/0001846069-25-000136.md) | [0.1 d](/filings/0001846069-26-000023.md) | [0.0](/filings/0001846069-26-000098.md) | [0.3 d](/filings/0001846069-26-000155.md) | [0.2 d](/filings/0001846069-25-000136.md) | [0.1 d](/filings/0001846069-26-000023.md) | [0.1](/filings/0001846069-26-000098.md) | [0.2 d](/filings/0001846069-26-000155.md) |
| Share repurchases | $m | [0.0 d](/filings/0001846069-24-000226.md) | [0.0 d](/filings/0001846069-26-000023.md) | [9.8](/filings/0001846069-25-000061.md) | [43.7 d](/filings/0001846069-25-000103.md) | [19.8 d](/filings/0001846069-25-000136.md) | [2.2 d](/filings/0001846069-26-000023.md) | [9.1](/filings/0001846069-26-000098.md) | [5.4 d](/filings/0001846069-26-000155.md) | [0.0 d](/filings/0001846069-25-000136.md) | [4.4 d](/filings/0001846069-26-000023.md) | [28.7](/filings/0001846069-26-000098.md) | [0.0 d](/filings/0001846069-26-000155.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [378](/filings/0001846069-23-000122.md) | [373](/filings/0001846069-24-000127.md) | [376](/filings/0001846069-24-000201.md) | [381](/filings/0001846069-24-000226.md) | [392](/filings/0001846069-25-000061.md) | [388](/filings/0001846069-25-000103.md) | [378](/filings/0001846069-25-000136.md) | [384](/filings/0001846069-26-000098.md) | [383](/filings/0001846069-26-000155.md) | [387](/filings/0001846069-25-000136.md) | [387](/filings/0001846069-26-000098.md) | [381](/filings/0001846069-26-000155.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.